Psychedelics-Focused MindMed Joins FTSE Russell 3000 Index, 'A True Honor'
A psychedelics-focused medicine company MindMed (NASDAQ: MNMD) reported Monday that has been added to the FTSE Russell 3000 index, effective June 25th. The FTSE Russell 3000 index measures the performance of the 3,000 largest companies in the United States.
